With its European and Chinese partners, Kiwi drug minnow AFT Pharmaceuticals plans a 1000-patient trial of a novel iron ...
Building an ethical business from day one can be a strategic advantage that attracts partners, talent and investors who care ...
Code compliance issues for architects and regulators are a significant bottleneck to building safe, efficient infrastructure ...
Regulators are starting to take notice. The EU AI Act, Canada's AI and Data Act and the U.S. Executive Order on Advancing ...
Investor's Business Daily on MSN
Nvidia Rallies. AI Giant Posts Upbeat Q3 Report. (Live Coverage)
Nvidia beat Wall Street’s targets for its fiscal third quarter and guided above estimates for the current period. Nvidia ...
The aseptic processing market is thriving due to the demand for sterile, self-stable products in food, beverage, and ...
The Council has reached agreement on its negotiating position for a regulation establishing an EU digital travel application.
The CNPV program aims to reduce drug review times to 1-2 months, raising concerns about safety and regulatory scrutiny. Critics argue that accelerated timelines may lead to safety issues and strain ...
Mercor’s valuation has surged dramatically, fueled by significant investor interest and a rapidly growing AI talent market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results